MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Myriad Genetics ROE Ratio 2011-2026 | MYGN
Annual ROE Ratio Myriad Genetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -99.43 | -18.16 | -33.62 | -12.64 | -2.81 | -6.03 | 0.42 | 13.59 | 2.8 | 16.75 | 12.11 | 24.51 | 20.19 | 17.64 | 17.77 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.51 | -99.43 | -3.13 |
Quarterly ROE Ratio Myriad Genetics
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -98.55 | -96.16 | -11.4 | -20.37 | -26.32 | -37.15 | -31.31 | -35.14 | -30.0 | -15.7 | -7.48 | -4.94 | 1.43 | 2.4 | -2.49 | -6.8 | -11.06 | -16.83 | -14.04 | -10.51 | -9.56 | -4.03 | -4.2 | -3.18 | -2.17 | -1.14 | 0.69 | 3.82 | 12.63 | 16.54 | 27.03 | 24.48 | 15.34 | 11.96 | 1.37 | 5.36 | 9.86 | 13.64 | 17.82 | 16.46 | 14.3 | 13.06 | 11.27 | 15.26 | 21.05 | 24.62 | 30.01 | 27.85 | 24.56 | 23.16 | 20.28 | 19.58 | 19.17 | 18.66 | 18.34 | 4.33 | 4.99 | 4.43 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 30.01 | -98.55 | -0.08 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
22.45 | $ 116.13 | 0.51 % | $ 35.3 B |  USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.64 | -1.8 % | $ 2.18 M | USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 25.51 | 4.29 % | $ 709 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 21.53 | 1.39 % | $ 1.15 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 127.88 | - | $ 20.3 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 15.96 | -2.15 % | $ 483 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 173.08 | 1.95 % | $ 8.58 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
419.18 | $ 90.12 | 1.36 % | $ 11.3 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 83.88 | -0.53 % | $ 5.66 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 415.61 | 1.23 % | $ 12 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.91 | -3.29 % | $ 8.45 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 27.57 | 0.35 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 7.04 | -0.14 % | $ 294 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.49 | -0.47 % | $ 2.06 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 52.73 | 0.01 % | $ 2.68 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.14 | - | $ 4.92 M | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 17.17 | -0.35 % | $ 384 M | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 100.45 | -1.68 % | $ 8.29 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 263.57 | -0.06 % | $ 21.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 470.21 | 0.14 % | $ 177 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 124.3 | 2.7 % | $ 5.81 B | USA |
 |
Trinity Biotech plc
TRIB
|
287.88 | $ 0.68 | 4.37 % | $ 61.9 M | Irlanda |
 |
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.46 | 1.99 % | $ 1.08 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 60.08 | -1.41 % | $ 3.59 B | USA |
 |
Natera
NTRA
|
-77.62 | $ 206.37 | 1.29 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 197.17 | 0.49 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | USA |